Rubric Capital Management LP Trevi Therapeutics, Inc. Transaction History
Rubric Capital Management LP
- $3.49 Billion
- Q1 2025
A detailed history of Rubric Capital Management LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 4,538,535 shares of TRVI stock, worth $30.8 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
4,538,535
Previous 4,205,129
7.93%
Holding current value
$30.8 Million
Previous $17.9 Million
59.36%
% of portfolio
0.82%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding TRVI
# of Institutions
145Shares Held
85.3MCall Options Held
1.51MPut Options Held
304K-
Nea Management Company, LLC Timonium, MD11.4MShares$77.2 Million6.78% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$69.7 Million4.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$26.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.49MShares$23.7 Million5.95% of portfolio
-
Bio Impact Capital LLC Cambridge, MA3.43MShares$23.3 Million3.99% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $396M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...